Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8789983 | Urologic Oncology: Seminars and Original Investigations | 2018 | 10 Pages |
Abstract
Nomograms can be used as prognostic guides to aid clinical decision-making for prostate cancer patients until further research addresses the limitations presented in this review. Strict definitions of end points should be added to future models and perhaps models could be enhanced with the incorporation of genomic variables or tumor specific parameters.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sarah B.Sc., Gerard Ph.D., Laure Ph.D., Claire M.Sc.,